您的位置: 首页 > 农业专利 > 详情页

COMPOSITION PHARMACEUTIQUE DESTINÉE À LA PRÉVENTION OU AU TRAITEMENT DE LA STÉATOSE HÉPATIQUE NON ALCOOLIQUE
专利权人:
LTD.;HANMI SCIENCE CO.
发明人:
LIM, SE YOUNG,PARK, SUNG HEE,SHIN, RYOUNG AE,CHOI, IN YOUNG,KWON, SE CHANG
申请号:
EP13757286
公开号:
EP2838549A4
申请日:
2013.03.08
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
The present invention relates to a pharmaceutical composition for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD), including a conjugate prepared by covalently linking an insulinotropic peptide, a non-peptidyl polymer and an immunoglobulin Fc region. The composition of the present invention maintains the in-vivo activity of the peptide at a relatively high level, and remarkably increases the blood half-life, thereby preventing triglyceride accumulation which is a typical feature of non-alcoholic fatty liver disease. Ultimately, it can be desirably employed for the prevention and treatment of non-alcoholic fatty liver disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充